glp-1 cardiovascular outcome trials receptor agonists and cardiorenal outcomes in type 2 diabetes: an updated meta-analysis of eight CVOTs | Diabetology GLP-1 Receptor Agonist Therapy With
Description
Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth (BALANCE) model: Request for applications, manufacturer
You're held accountable by group members
Long-Term Persistence of Adaptive Thermogenesis in Subjects Who Have Maintained a Reduced Body Weight
Effects of dapagliflozin on blood pressure in hypertensive diabetic patients on renin-angiotensin system blockade
2018;13(5):e0198024
